U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: over 10,000 records

Showing results for "feasible".

  1. Ellis, Charles | Digital Healthcare Research

    digital.ahrq.gov/principal-investigator/ellis-charles
    January 01, 2023 - a telerehabilitation approach among stroke survivors with aphasia, finding it was a cost-effective, feasible

  2. Executive Summary | Agency for Healthcare Research and Quality

    www.ahrq.gov/research/findings/final-reports/prospectscare/prospsum.html
    July 01, 2018 - identified opportunities for measuring care coordination using electronic data that are likely to be feasible … Panelists also discussed some measurement opportunities that are promising in the long term, but likely not feasible … A limited application of this kind of measure is likely to be feasible in some cases within the next … possibility, even while recognizing many challenges that must be overcome to make such measurement feasible

  3. Measure: Developmental Screening Follow-up: Follow-up Referral Tracking (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra-16-p001-3-ef.pdf
    April 01, 2016 - often are not available in structured fields in the EHR; therefore, this measure is not currently feasible … are documented and available in the paper and electronic medical records; therefore, this measure is feasible … forms reliability eMeasure testing indicated that in one site, while the eMeasure was technically feasible … Therefore, the eMeasure was not implementable at that site at this time, but it would be feasible with

  4. Chipra-88-Measure-1-Section-2-Attachment-4 (xls file)

    www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-2-attachment-4.xlsx
    January 17, 2017 - drop-down menu item Feasibility Comments Must enter comments if "Nonfeasible, cannot do today" or "Feasible … Accurately Differentiate Quality of Performance Across Providers Measure N/A N/A N/A N/A N/A N/A N/A N/A Feasible … Can do today Yes Feasible. … Preschool-Aged Children CPOE Demographics Code Vendor specific Once per measurement period g No No Feasible … with workflow mod/changes to EHR Feasible with workflow mod/changes to EHR 3 Neither Disagree Nor Agree

  5. Surgery | Digital Healthcare Research

    digital.ahrq.gov/type-care/surgery
    January 01, 2023 - patient-reported outcome measures in the National Surgical Quality Improvement Program is not only feasible … developed a decision making tool for patients with asymptomatic carotid stenosis and concluded that it was feasible

  6. Chipra204-Materials Vib (pdf file)

    www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA204-Materials_VIB.pdf
    January 01, 2012 - 109 1 2 3 4 5 6 7 8 9 IMPORTANCE: 1 (not important) – 9 (extremely important) FEASIBILITY: 1 (not feasible … ) – 9 (v ery feasible) VALIDITY: 1 (not v alid) – 9 (extremely v alid) CLINICALLY RELEVANT: 1 (not … 2 3 4 5 6 7 8 9 Total IMPORTANCE: 1 (not important) – 9 (extremely important) FEASIBILITY: 1 (not feasible … ) – 9 (very feasible) VALIDITY: 1 (not valid) – 9 (extremely valid) CLINICALLY RELEVANT: 1 (not clinically

  7. Chipra204-Materials Vib (pdf file)

    www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA204-Materials_VIB.pdf
    January 01, 2012 - 109 1 2 3 4 5 6 7 8 9 IMPORTANCE: 1 (not important) – 9 (extremely important) FEASIBILITY: 1 (not feasible … ) – 9 (v ery feasible) VALIDITY: 1 (not v alid) – 9 (extremely v alid) CLINICALLY RELEVANT: 1 (not … 2 3 4 5 6 7 8 9 Total IMPORTANCE: 1 (not important) – 9 (extremely important) FEASIBILITY: 1 (not feasible … ) – 9 (very feasible) VALIDITY: 1 (not valid) – 9 (extremely valid) CLINICALLY RELEVANT: 1 (not clinically

  8. Chipra205-Materials Vib (pdf file)

    www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA205-Materials_VIB.pdf
    January 01, 2013 - 108 1 2 3 4 5 6 7 8 9 IMPORTANCE: 1 (not important) – 9 (extremely important) FEASIBILITY: 1 (not feasible … ) – 9 (v ery feasible) VALIDITY: 1 (not v alid) – 9 (extremely v alid) CLINICALLY RELEVANT: 1 (not … 2 3 4 5 6 7 8 9 Total IMPORTANCE: 1 (not important) – 9 (extremely important) FEASIBILITY: 1 (not feasible … ) – 9 (very feasible) VALIDITY: 1 (not valid) – 9 (extremely valid) CLINICALLY RELEVANT: 1 (not clinically

  9. Chipra205-Materials Vib (pdf file)

    www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA205-Materials_VIB.pdf
    January 01, 2013 - 108 1 2 3 4 5 6 7 8 9 IMPORTANCE: 1 (not important) – 9 (extremely important) FEASIBILITY: 1 (not feasible … ) – 9 (v ery feasible) VALIDITY: 1 (not v alid) – 9 (extremely v alid) CLINICALLY RELEVANT: 1 (not … 2 3 4 5 6 7 8 9 Total IMPORTANCE: 1 (not important) – 9 (extremely important) FEASIBILITY: 1 (not feasible … ) – 9 (very feasible) VALIDITY: 1 (not valid) – 9 (extremely valid) CLINICALLY RELEVANT: 1 (not clinically

  10. Chipra204-Materials Vib (pdf file)

    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA204-Materials_VIB.pdf
    January 01, 2012 - 109 1 2 3 4 5 6 7 8 9 IMPORTANCE: 1 (not important) – 9 (extremely important) FEASIBILITY: 1 (not feasible … ) – 9 (v ery feasible) VALIDITY: 1 (not v alid) – 9 (extremely v alid) CLINICALLY RELEVANT: 1 (not … 2 3 4 5 6 7 8 9 Total IMPORTANCE: 1 (not important) – 9 (extremely important) FEASIBILITY: 1 (not feasible … ) – 9 (very feasible) VALIDITY: 1 (not valid) – 9 (extremely valid) CLINICALLY RELEVANT: 1 (not clinically

  11. Chipra205-Materials Vib (pdf file)

    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA205-Materials_VIB.pdf
    January 01, 2013 - 108 1 2 3 4 5 6 7 8 9 IMPORTANCE: 1 (not important) – 9 (extremely important) FEASIBILITY: 1 (not feasible … ) – 9 (v ery feasible) VALIDITY: 1 (not v alid) – 9 (extremely v alid) CLINICALLY RELEVANT: 1 (not … 2 3 4 5 6 7 8 9 Total IMPORTANCE: 1 (not important) – 9 (extremely important) FEASIBILITY: 1 (not feasible … ) – 9 (very feasible) VALIDITY: 1 (not valid) – 9 (extremely valid) CLINICALLY RELEVANT: 1 (not clinically

  12. Chipra204-Materials Vib (pdf file)

    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA204-Materials_VIB.pdf
    January 01, 2012 - 109 1 2 3 4 5 6 7 8 9 IMPORTANCE: 1 (not important) – 9 (extremely important) FEASIBILITY: 1 (not feasible … ) – 9 (v ery feasible) VALIDITY: 1 (not v alid) – 9 (extremely v alid) CLINICALLY RELEVANT: 1 (not … 2 3 4 5 6 7 8 9 Total IMPORTANCE: 1 (not important) – 9 (extremely important) FEASIBILITY: 1 (not feasible … ) – 9 (very feasible) VALIDITY: 1 (not valid) – 9 (extremely valid) CLINICALLY RELEVANT: 1 (not clinically

  13. Chipra205-Materials Vib (pdf file)

    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA205-Materials_VIB.pdf
    January 01, 2013 - 108 1 2 3 4 5 6 7 8 9 IMPORTANCE: 1 (not important) – 9 (extremely important) FEASIBILITY: 1 (not feasible … ) – 9 (v ery feasible) VALIDITY: 1 (not v alid) – 9 (extremely v alid) CLINICALLY RELEVANT: 1 (not … 2 3 4 5 6 7 8 9 Total IMPORTANCE: 1 (not important) – 9 (extremely important) FEASIBILITY: 1 (not feasible … ) – 9 (very feasible) VALIDITY: 1 (not valid) – 9 (extremely valid) CLINICALLY RELEVANT: 1 (not clinically

  14. Chipra204-Materials Vib (pdf file)

    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA204-Materials_VIB.pdf
    January 01, 2012 - 109 1 2 3 4 5 6 7 8 9 IMPORTANCE: 1 (not important) – 9 (extremely important) FEASIBILITY: 1 (not feasible … ) – 9 (v ery feasible) VALIDITY: 1 (not v alid) – 9 (extremely v alid) CLINICALLY RELEVANT: 1 (not … 2 3 4 5 6 7 8 9 Total IMPORTANCE: 1 (not important) – 9 (extremely important) FEASIBILITY: 1 (not feasible … ) – 9 (very feasible) VALIDITY: 1 (not valid) – 9 (extremely valid) CLINICALLY RELEVANT: 1 (not clinically

  15. Chipra205-Materials Vib (pdf file)

    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA205-Materials_VIB.pdf
    January 01, 2013 - 108 1 2 3 4 5 6 7 8 9 IMPORTANCE: 1 (not important) – 9 (extremely important) FEASIBILITY: 1 (not feasible … ) – 9 (v ery feasible) VALIDITY: 1 (not v alid) – 9 (extremely v alid) CLINICALLY RELEVANT: 1 (not … 2 3 4 5 6 7 8 9 Total IMPORTANCE: 1 (not important) – 9 (extremely important) FEASIBILITY: 1 (not feasible … ) – 9 (very feasible) VALIDITY: 1 (not valid) – 9 (extremely valid) CLINICALLY RELEVANT: 1 (not clinically

  16. Chipra204-Materials Vib (pdf file)

    www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA204-Materials_VIB.pdf
    January 01, 2012 - 109 1 2 3 4 5 6 7 8 9 IMPORTANCE: 1 (not important) – 9 (extremely important) FEASIBILITY: 1 (not feasible … ) – 9 (v ery feasible) VALIDITY: 1 (not v alid) – 9 (extremely v alid) CLINICALLY RELEVANT: 1 (not … 2 3 4 5 6 7 8 9 Total IMPORTANCE: 1 (not important) – 9 (extremely important) FEASIBILITY: 1 (not feasible … ) – 9 (very feasible) VALIDITY: 1 (not valid) – 9 (extremely valid) CLINICALLY RELEVANT: 1 (not clinically

  17. Chipra205-Materials Vib (pdf file)

    www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA205-Materials_VIB.pdf
    January 01, 2013 - 108 1 2 3 4 5 6 7 8 9 IMPORTANCE: 1 (not important) – 9 (extremely important) FEASIBILITY: 1 (not feasible … ) – 9 (v ery feasible) VALIDITY: 1 (not v alid) – 9 (extremely v alid) CLINICALLY RELEVANT: 1 (not … 2 3 4 5 6 7 8 9 Total IMPORTANCE: 1 (not important) – 9 (extremely important) FEASIBILITY: 1 (not feasible … ) – 9 (very feasible) VALIDITY: 1 (not valid) – 9 (extremely valid) CLINICALLY RELEVANT: 1 (not clinically

  18. Chipra204-Materials Vib (pdf file)

    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA204-Materials_VIB.pdf
    January 01, 2012 - 109 1 2 3 4 5 6 7 8 9 IMPORTANCE: 1 (not important) – 9 (extremely important) FEASIBILITY: 1 (not feasible … ) – 9 (v ery feasible) VALIDITY: 1 (not v alid) – 9 (extremely v alid) CLINICALLY RELEVANT: 1 (not … 2 3 4 5 6 7 8 9 Total IMPORTANCE: 1 (not important) – 9 (extremely important) FEASIBILITY: 1 (not feasible … ) – 9 (very feasible) VALIDITY: 1 (not valid) – 9 (extremely valid) CLINICALLY RELEVANT: 1 (not clinically

  19. Chipra205-Materials Vib (pdf file)

    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA205-Materials_VIB.pdf
    January 01, 2013 - 108 1 2 3 4 5 6 7 8 9 IMPORTANCE: 1 (not important) – 9 (extremely important) FEASIBILITY: 1 (not feasible … ) – 9 (v ery feasible) VALIDITY: 1 (not v alid) – 9 (extremely v alid) CLINICALLY RELEVANT: 1 (not … 2 3 4 5 6 7 8 9 Total IMPORTANCE: 1 (not important) – 9 (extremely important) FEASIBILITY: 1 (not feasible … ) – 9 (very feasible) VALIDITY: 1 (not valid) – 9 (extremely valid) CLINICALLY RELEVANT: 1 (not clinically

  20. Table B-1. Priority Groups of Survey Measures Based on Feasibility and Degree of Focus on Care Coordination | Agency for Healthcare Research and Quality

    www.ahrq.gov/research/findings/final-reports/pcpaccountability/pcpacctabb1.html
    July 01, 2018 - These measures are likely less feasible and less relevant.
SHARE:
Facebook Twitter Print Facebook Share

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

www.ahrq.gov (1796)

digital.ahrq.gov (1167)

effectivehealthcare-admin.ahrq.gov (1051)

psnet.ahrq.gov (1037)

ce.effectivehealthcare.ahrq.gov (1016)

effectivehealthcare.ahrq.gov (1008)

www.uspreventiveservicestaskforce.org (621)

www.qualitymeasures.ahrq.gov (580)

cmext.ahrq.gov (470)

www.talkingquality.ahrq.gov (456)

www.healthcare411.ahrq.gov (446)

www.monahrq.ahrq.gov (446)

www.innovations.ahrq.gov (445)

www.cahps.ahrq.gov (413)

www.cpsi.ahrq.gov (229)

pcmh.ahrq.gov (200)

hcup-us.ahrq.gov (190)

pbrn.ahrq.gov (187)

srdr.ahrq.gov (179)

monahrq.ahrq.gov (176)

healthcare411.ahrq.gov (175)

cahps.ahrq.gov (174)

patientregistry.ahrq.gov (151)

preventiveservices.ahrq.gov (151)

talkingquality.ahrq.gov (151)

ahrqpubs.ahrq.gov (146)

teamstepps.ahrq.gov (120)

cdsic.ahrq.gov (77)

meps.ahrq.gov (44)

cds.ahrq.gov (33)

qualityindicators.ahrq.gov (17)

covid-acts.ahrq.gov (7)

staging-meps.ahrq.gov (5)

cahpsdatabase.ahrq.gov (3)

datatools.ahrq.gov (2)

srdrplus.ahrq.gov (2)

jamanetwork.com (1)